Complete Genomics, a leading innovator in genomic sequencing, announced at the NextGen Omics & Spatial Biology Conference that it has entered a commercial partnership with Human Cell Atlas (HCA) to offer its STOmics spatial transcriptomics products to HCA members.

Human Cell Atlas (HCA), an international collaborative research consortium, is mapping all cell types in the healthy body, across time from development to adulthood. This comprehensive reference map of human cells is transforming researchers’ understanding of health and disease driving major advances in healthcare and medicine worldwide.

Spatio-Temporal Enhanced Resolution Omics sequencing, or Stereo-seq, is a cutting-edge spatial transcriptomics technology at the core of all Complete Genomics spatial biology solutions that enables unmatched access to the spatial transcriptome, providing researchers with a powerful tool to understand complex biological processes at the molecular level. The technology supports diverse tissue preparations, including fresh, fixed, frozen and FFPE samples for a wide range of tissues and species including humans, animals and plants.

In the coming years, new spatial genomics technologies will be critical for accelerating progress toward HCA’s goal of mapping all cell types in the human body,” said John Randell, HCA Executive Director. “We are glad to welcome Complete Genomics to the HCA Commercial Discount Program to facilitate access to STOmics products for HCA researchers in North America.”

The Complete Genomics’ DNBSEQ™ platform is the engine that powers Stereo-seq by providing the high-throughput, high-quality sequencing necessary to capture and analyze spatial gene expression data across large tissue areas with high resolution. Stereo-seq DNB chips have spots with a diameter of 0.22 µm and a center-to-center distance of 0.5 µm which provides up to 400 spots per 100 µm2, thereby allowing whole transcriptome mapping at true single cell resolution.

“HCA members will find that Stereo-seq is uniquely positioned to elevate research that requires comprehensive spatial gene expression analysis across large tissue areas,” said Rob Tarbox, VP of Product and Marketing at Complete Genomics.

Source – PR Newswire